Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Sarcoma 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 49Central Nervous System Neoplasms 46Medulloblastoma 26Brain Neoplasms 23Astrocytoma 23Sarcoma 15Testicular Neoplasms 14Oligodendroglioma 13Familial ependymoma 13Ovarian Neoplasms 12Glioblastoma 12Testicular Germ Cell Tumor 11Lymphoma 11Neuroectodermal Tumors, Primitive, Peripheral 10Wilms Tumor 9Optic Nerve Glioma 9Gliosarcoma 9Ependymoma 9Choroid Plexus Neoplasms 9Rhabdoid Tumor 8Retinoblastoma 8Glioma 8Teratoma 7Kidney Neoplasms 7Osteosarcoma 6Head and Neck Neoplasms 6Burkitt Lymphoma 6Recurrence 5Neuroectodermal Tumors, Primitive 5Esthesioneuroblastoma, Olfactory 5

Interventions

Oxaliplatin 2Docetaxel 2Temozolomide 1Ritonavir 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Irinotecan 1Indinavir 1Fluorodeoxyglucose F18 1Filgrastim 1FPP(RGD)2 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Filgrastim × CNS × Clear all
NCT00005952 2013-06-20

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Duke University

Phase 1/2 Completed
30 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Testicular Germ Cell Tumor, Astrocytoma, Head and Neck Neoplasms, Kidney Neoplasms, Medulloblastoma, Nasopharyngeal Neoplasms, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡